Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 708459

Difference in glucagon-like peptide-1 concentrations between C-peptide negative type 1 diabetic mellitus patients and healthy controls


Zibar, Karin; Knežević-Ćuća, Jadranka; Blaslov, Kristina; Bulum, Tomislav; Smirčić-Duvnjak, Lea.
Difference in glucagon-like peptide-1 concentrations between C-peptide negative type 1 diabetic mellitus patients and healthy controls // Annals of clinical biochemistry, 52 (2015), 2; 220-225 doi:10.1177/0004563214544709 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 708459 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Difference in glucagon-like peptide-1 concentrations between C-peptide negative type 1 diabetic mellitus patients and healthy controls

Autori
Zibar, Karin ; Knežević-Ćuća, Jadranka ; Blaslov, Kristina ; Bulum, Tomislav ; Smirčić-Duvnjak, Lea.

Izvornik
Annals of clinical biochemistry (0004-5632) 52 (2015), 2; 220-225

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
diabetes

Sažetak
The role of glucagon-like peptide-1 (GLP-1) has become a new scientific interest in the field of patho- physiology of type 1 diabetes mellitus (T1DM), but the results of the published studies were contradictory. The aim of our study was therefore to measure fasting and postprandial GLP-1 concentrations in T1DM patients and in healthy controls and to examine the difference in those concentrations between the two groups of subjects. The cross-sectional study included 30 C-peptide negative T1DM patients, median age 37 years (20–59), with disease duration 22 years (3–45), and 10 healthy controls, median age 30 years (27–47). Fasting and postprandial total and active GLP-1 concentrations were measured by ELISA (ALPCO, USA). The data were statistically analysed by SPSS, and significance level was accepted at P < 0.05. Both fasting total and active GLP-1 concentrations were significantly lower in T1DM patients (total 0.4pmol/L, 0–6.4 and active 0.2pmol/L, 0–1.9) compared with healthy controls (total 3.23pmol/L, 0.2–5.5 and active 0.8pmol/L, 0.2–3.6), P = 0.008 for total GLP-1 and P = 0.001 for active GLP-1. After adjustment for age, sex and body mass index, binary logistic regression showed that both fasting total and active GLP-1 remained significantly independently lower in T1DM patients (total GLP-1: OR 2.43, 95% CI 1.203– 4.909 and active GLP-1: OR 8.73, 95% CI 1.472– 51.787). T1DM patients had independently lower total and active GLP-1 fasting concentrations in comparison with healthy people, which supports the potential therapeutic role of incretin therapy, along with insulin therapy, in T1DM patients.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Projekti:
045-1080230-0516 - Metabolički sindrom u šećernoj bolesti tipa 1 (Smirčić-Duvnjak, Lea, MZOS ) ( CroRIS)

Ustanove:
Klinička bolnica "Merkur",
Klinika za dijabetes, endokrinologiju i bolesti metabolizma Vuk Vrhovac,
Medicinski fakultet, Zagreb

Poveznice na cjeloviti tekst rada:

doi acb.sagepub.com

Citiraj ovu publikaciju:

Zibar, Karin; Knežević-Ćuća, Jadranka; Blaslov, Kristina; Bulum, Tomislav; Smirčić-Duvnjak, Lea.
Difference in glucagon-like peptide-1 concentrations between C-peptide negative type 1 diabetic mellitus patients and healthy controls // Annals of clinical biochemistry, 52 (2015), 2; 220-225 doi:10.1177/0004563214544709 (međunarodna recenzija, članak, znanstveni)
Zibar, K., Knežević-Ćuća, J., Blaslov, K., Bulum, T. & Smirčić-Duvnjak, L. (2015) Difference in glucagon-like peptide-1 concentrations between C-peptide negative type 1 diabetic mellitus patients and healthy controls. Annals of clinical biochemistry, 52 (2), 220-225 doi:10.1177/0004563214544709.
@article{article, author = {Zibar, Karin and Kne\v{z}evi\'{c}-\'{C}u\'{c}a, Jadranka and Blaslov, Kristina and Bulum, Tomislav and Smir\v{c}i\'{c}-Duvnjak, Lea.}, year = {2015}, pages = {220-225}, DOI = {10.1177/0004563214544709}, keywords = {diabetes}, journal = {Annals of clinical biochemistry}, doi = {10.1177/0004563214544709}, volume = {52}, number = {2}, issn = {0004-5632}, title = {Difference in glucagon-like peptide-1 concentrations between C-peptide negative type 1 diabetic mellitus patients and healthy controls}, keyword = {diabetes} }
@article{article, author = {Zibar, Karin and Kne\v{z}evi\'{c}-\'{C}u\'{c}a, Jadranka and Blaslov, Kristina and Bulum, Tomislav and Smir\v{c}i\'{c}-Duvnjak, Lea.}, year = {2015}, pages = {220-225}, DOI = {10.1177/0004563214544709}, keywords = {diabetes}, journal = {Annals of clinical biochemistry}, doi = {10.1177/0004563214544709}, volume = {52}, number = {2}, issn = {0004-5632}, title = {Difference in glucagon-like peptide-1 concentrations between C-peptide negative type 1 diabetic mellitus patients and healthy controls}, keyword = {diabetes} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font